Browse articles from EyeWorld.org related to ASCRS. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

ASCRS leadership discusses pilocarpine treatment for presbyopia correction

Following updates to prescribing information on pilocarpine 1.25% and release of the ASCRS Consensus Statement on the topic, several members of the ASCRS leadership sat down to discuss presbyopia-correcting drops. Sumit “Sam” Garg, MD, EyeWorld Chief Medical Editor, led a discussion with Elizabeth Yeu, MD, Cathleen McCabe, MD, and Douglas Rhee, MD. They addressed some of the reported adverse events, how to examine and speak to patients about the product, uses of pilocarpine in the glaucoma field, and more.

Comments Off on ASCRS leadership discusses pilocarpine treatment for presbyopia correction

ASCRS Consensus Statement on VUITY

In August, the Prescribing Information for VUITY (pilocarpine) was updated following a voluntary submission by Allergan to the FDA. This ASCRS Task Force was convened to develop an understanding of the data and a preliminary consensus on appropriate counseling of patients regarding risks associated with the use of Vuity.

Comments Off on ASCRS Consensus Statement on VUITY

Ophthalmologist perspective: What the media and the FDA aren’t saying about LASIK

The FDA issued draft guidance for LASIK patient labeling recommendations in July 2022 that ASCRS and refractive surgeons consider “highly biased and misleading to potential patients.” During the FDA’s comment period, ASCRS submitted these and more specific comments. Last week, the New York Times, CBS, local news outlets, and trade publications picked up the story, but ophthalmologists say most coverage does not convey the whole story.

Comments Off on Ophthalmologist perspective: What the media and the FDA aren’t saying about LASIK

ASCRS Education: a year in review and what’s next

This year, ASCRS hosted a robust, in-person Annual Meeting, expanding its offerings and opportunities at this premier event geared toward anterior segment surgeons. The Society developed new on-demand programming and functionality to benefit members, it hosted the first ASCRS Summer Meeting, and much more.

Comments Off on ASCRS Education: a year in review and what’s next

Government Relations update: prior authorization success and more

In a major victory for ophthalmologists and their patients, ASCRS' advocacy led one of the largest insurers in the nation to rescind its harmful prior authorization policy for cataract surgery in nearly every state. This article provides details on this and other updates from the ASCRS Government Relations team.

Comments Off on Government Relations update: prior authorization success and more